Introduction
The issue of whether to test healthcare workers for the presence of blood borne viruses arouses much controversy and indignation. Unfortunately, the heat of this debate has often been fuelled by media sensationalisAn or medical examples of shroud waving, which have served to obfuscate the real issues which lie at the heart ofthis proposal. This review will focus on three virus infections, HIV, hepatitis B virus (HBV) and hepatitis C virus (HCV).
To examine the ethical considerations involved in this question properly, it is necessary to understand the natural history, potential for vaccination and available treatment of each of these conditions, as well as review the evidence that an infected healthcare worker poses any risk to the health of their patients. Only on this basis can one judge whether or not mandatory testing of healthcare workers will benefit the individual healthcare worker and/or their employees and/or their patients and/or society at large. By examining the pros and cons of such proposed testing regimes for each of these groups, a balanced decision on the ethical issues can be reached. Once the ethical balances have been set, it will be possible to assess the logistics and costs in obtaining this supposed benefit which would accrue from the testing of healthcare workers. In the real life debate, this decision and who makes it seems most likely to determine the future course of policy and practice.
The viruses concerned The salient features of the three viruses, HIV, HBV and HCV, are summarised in the table. Several important differences need to be emphasised. From HIV acquisition, an infected individual remains infectious to a greater or lesser degree throughout the rest of his/her life.
There are no reported or substantiated cases of naturally acquired or treatment induced eradication of HIV infection.
In contrast, only a small percentage of individuals infected by HBV will be infectious to others for more than a few months after infection. There are well validated laboratory tests to identify these individuals and treatments offer the possibility of reducing or even removing infectivity. Furthermore, in the case of HBV infection there is an effective and safe vaccine which will prevent infection in the majority of recipients.
Neither HIV nor HCV have an adequate vaccine available at present.' Tests are only just beginning to be available for HCV infectivity, which, on present data, is presumed to be for life in up to 50% of infected individuals. Although treatment exists to reduce the severity of HCV induced hepatitis, there is little evidence of an effect on the transmission of this infection.
Evidence of transmission of infections between patients and healthcare workers There have been documented cases of transmission of both HIV and HBV from healthcare workers to patients,2-6 and reports of all three viruses being transmitted from patients to healthcare workers.7-" Over the past four years, the major concern amongst the general population about the risk of becoming infected by healthcare workers has centred on those with HIV infection. This has been amplified by specific reports, especially the transmission of HIV from a Florida dentist with the acquired immunodeficiency syndrome to five of his patients,3 and the UK media response to the reports of HIV infected healthcare workers in 1991 A healthcare worker who tested HIV antibody positive would be bound by professional responsibility to review and amend their working practices to remove the risk of infecting their patients. Clearly the extent to which a general practitioner or a surgeon has to change their practice will vary considerably.
The same principle would be clearly true for healthcare workers who have surface antigen positive hepatitis B or who have tested positive for HCV. However, although an individual healthcare worker may be driven towards the "first do no harm principle", their personal change in circumstances and work practices may influence their decision or its timing. Although we ought to be able to feel secure that a potentially infectious doctor or nurse would be driven by expected altruism to modify their practices, cases may occur where the individual may feel reluctant to amend their practice or stop working for financial reasons. This has recently been highlighted by the case of the surgeon who had hepatitis B and who continued working in order to support himself and his family.22
In the case of transmission of hepatitis B from healthcare workers to patients, it is clear that this should be avoidable by the delivery of the safe and effective vaccine which, although it has been in clinical use for over 10 years, has received a poor response by healthcare workers. 
On the other hand, those individuals who have not yet been vaccinated either because of their own or their health authority's intransigence may have already contracted hepatitis B, and in those cases where e antigenaemia is present would have to modify their practice. Closing the loop to satisfy the needs of both healthcare workers and their patients requires clear guidance on the financial and social treatment which doctors and other healthcare workers will face if they are found to be e antigen positive. This should include the option for treatment with interferon which may increase seroconversion and permit them to return to work. Failing this, the clear onus should be on the NHS to ensure that a coordinated response encourages healthcare workers to act in the best interest of their patients and themselves. At present, the NHS Injury Benefit Scheme allows for up to 85% of pre-injury NHS earnings. However, it states that "it must be established that the injury or disease was acquired during the course of work", something which the legal department of one journal describes as "next to impossible".26 If financial reimbursement was made available to all NHS employees found to be infectious, the reticence for self-identification would at least be partially alleviated. The origin of the infection should not influence the right to, or size of, reimbursement.
At present, there appears to be no central government guidelines. New A possible scenario in any public debate is the search for a compromise. In this context, it is hoped that the obvious concentration on risks to patients from surgeons and others who regularly perform the most exposure prone procedures will not lead to a split in the health requirements of different doctors and healthcare workers.
THE EDUCATOR
More recently, there has been much discussion over the introduction of vetting medical and dental students before entry to medical school.32-34 e Committee ofVice Chancellors and Principals has issued guidelines which are to come into force by 1996 which state that Newell, Barton successful applicants must have proof "of non infectivity and immunisation against hepatitis B by the time of registration".35 This has resulted already in one applicant being refused entry on these grounds. 36 It is being argued that this policy is an overreaction and will deny prospective medical students careers in lower risk specialties such as psychiatry, microbiology, etc., and will inadvertently discriminate against applicants from countries where carrier rates are higher. It also precludes the possibility of successful treatment with interferon. However, screening of prospective medical students at secondary school will identify those individuals deemed to be infectious early on when they have the greatest chance of adapting to a new career, as opposed to being identified either half way through their medical training or once they have infected their patients. A compromise might be that secondary school screening and immunisation would allow those identified as infectious to either switch career or continue into medical school and go into modified courses leading to non-invasive careers. If therapy or natural history altered their infectious status then, this could act as a module for transferring to the full medical course.
Ethical balance In summary, for hepatitis B infection it is clear that it is in the best of interests of both healthcare workers and patients that all healthcare workers are vaccinated and protected from acquiring HBV infection and hence this will prevent patients being at risk of infection. The only negative aspects to this are potentially in those individuals in whom vaccination does not promote a sufficient immune response or those individuals who are already infected with hepatitis B and remain antigenaemic. The provision of clear indications for the financial and professional management of these individuals is long overdue. By minimising the negative aspect of the knowledge of antigen positivity for the individual healthcare worker, central government can add great emphasis to the screening system and help to maintain the safety of patients.
In the case of HIV infection no such vaccine exists, but the potential risk to patients is less well defined. For the individual healthcare worker the knowledge of their own HIV seropositivity would be a cause of personal health concern, but surely knowledge that they had exposed patients to an infectious risk may be an even greater psychological burden to bear. Another dilemma is posed by the situation of visiting specialists and locums from abroad who may be infected. Would they be tested on arrival and expected to wait three months before being allowed to work in this country?
Yet another concern has been raised about the stance the Association of British Insurers would take on compulsory testing of healthcare workers. They have stated that if an applicant has a routine negative test, an extra premium will not be charged unless risk factors are present, be they disease, lifestyle or occupation.'7
Conclusion
The screening of healthcare workers for blood borne viruses has been hotly debated and, at present, the risk to patients appears to stem mainly from those surgeons identified as carrying hepatitis e antigen and therefore mandatory blanket screening of healthcare workers for HCV and HIV appears unfounded. However, it is the clear moral obligation of all healthcare workers to protect the health of their patients. If the profession fails, either singly or collectively, to honour this contract it can be envisaged that central government or individual Trusts will set the future agenda and thus impose their own level of testing. By emphasising professional obligations and supporting the hepatitis B prevention scheme, all doctors will demonstrate clearly their willingness and ability to act in the very best interests of their patients. The results of "lookbacks" on the patients ofhealthcare workers known to have HIV infection, and studies of the transmission characteristics of HCV should inform future decisions regarding testing for these viruses. It is hoped that this will constitute a prime example of repeated negative studies supporting common sense and good ethical and medical practice. 
